Envoy Medical (NASDAQ:COCH) Coverage Initiated by Analysts at Brookline Capital Management

Brookline Capital Management started coverage on shares of Envoy Medical (NASDAQ:COCH) in a research report released on Monday morning, Benzinga reports. The brokerage issued a buy rating and a $9.00 target price on the stock.

Separately, Ascendiant Capital Markets raised their target price on shares of Envoy Medical from $8.50 to $8.75 and gave the stock a buy rating in a research report on Tuesday, September 3rd.

Envoy Medical Stock Performance

Shares of NASDAQ:COCH opened at $2.46 on Monday. The stock’s 50-day moving average is $2.99 and its 200 day moving average is $3.18. Envoy Medical has a 1 year low of $0.75 and a 1 year high of $11.46.

Envoy Medical (NASDAQ:COCH) last posted its earnings results on Monday, August 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.03). The firm had revenue of $0.07 million during the quarter, compared to analysts’ expectations of $0.08 million. As a group, analysts forecast that Envoy Medical will post -1.22 EPS for the current fiscal year.

Hedge Funds Weigh In On Envoy Medical

A hedge fund recently bought a new stake in Envoy Medical stock. WealthTrust Asset Management LLC purchased a new position in Envoy Medical, Inc. (NASDAQ:COCH) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 11,316 shares of the company’s stock, valued at approximately $44,000. WealthTrust Asset Management LLC owned approximately 0.06% of Envoy Medical at the end of the most recent reporting period. 8.59% of the stock is owned by institutional investors and hedge funds.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.